Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial
scientific article published on September 2012
Author/s
author: Christian Thiede, Eva Mischak-Weissinger, Gerhard Ehninger, Ulrich Germing, Uwe Platzbecker, Martin Bornhäuser, Dietrich W Beelen, Martin Wermke, Katja Sockel, Jürgen Finke, Rudolf Trenschel, Guido Kobbe
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.